-- 
Israel Stocks: Ampal-American, Bioline, Ceragon, Elbit Systems

-- B y   R o n i t   G o o d m a n
-- 
2011-05-17T10:31:21Z

-- http://www.bloomberg.com/news/2011-05-17/israel-stocks-ampal-american-bioline-ceragon-elbit-systems.html
Israel ’s TA-25 Index advanced for a
second day, increasing 0.3 percent to 1,291.85 at 12:45 p.m. in
Tel Aviv.  The following stocks rose or fell today. Symbols are in
parentheses.  Ampal-American Israel (AMPL)  Corp climbed the most
since March 16, jumping 9.1 percent to 4.388 shekels. The owner
of a 12.5 percent stake in East Mediterranean Gas Co. said gas
deliveries to Israel may resume at the end of the month once new
security measures have been implemented.  Separately, the company reported first-quarter net income
of $17.2 million after a year-earlier loss.  Bioline RX (BLRX IT) gained for the first time in seven
days, rising 2.6 percent to 1.93 shekels. The biopharmaceutical
company said it’s developing BL-7030 for targeted cancer
therapy.  Ceragon Networks Ltd. (CRNT)   fell to the lowest since
March 24, dropping 4.6 percent to 38.39 shekels. The wireless
networking-systems developer reported a first-quarter loss of
$21.4 million after a profit of $3 million a year earlier.  Clal Biotechnology Industries Ltd. (CBI)   rose the most
in almost a week, advancing 2.1 percent to 20.54 shekels.
CureTech, a unit of the investor in biological companies and
 Teva Pharmaceutical Industries Ltd. (TEVA)   said CT-011 met
its primary endpoint in a Phase II trial in patients with
Diffuse Large B Cell Lymphoma. Teva slipped 0.7 percent to
174.70 shekels.  Elbit Systems Ltd. (ESLT)   climbed the most since April
11, adding 2.2 percent to 183.10 shekels. Israel’s biggest non-
government defense contractor won an order worth $32.7 million
to supply an unidentified Asian army with advanced training
systems for its armor and infantry forces.  To contact the reporter on this story:
Ronit Goodman in  Tel Aviv  at 
 rgoodman9@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  